ALPS Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $617K | Sell |
72,863
-25,959
| -26% | -$220K | ﹤0.01% | 596 |
|
|
2025
Q1 | $795K | Sell |
98,822
-16,950
| -15% | -$136K | ﹤0.01% | 527 |
|
|
2024
Q4 | $1.04M | Buy |
115,772
+7,039
| +6% | +$63.2K | 0.01% | 471 |
|
|
2024
Q3 | $797K | Sell |
108,733
-2,827
| -3% | -$20.7K | 0.01% | 552 |
|
|
2024
Q2 | $637K | Buy |
111,560
+9,554
| +9% | +$54.6K | ﹤0.01% | 546 |
|
|
2024
Q1 | $511K | Buy |
102,006
+1,482
| +1% | +$7.43K | ﹤0.01% | 588 |
|
|
2023
Q4 | $904K | Sell |
100,524
-5,287
| -5% | -$47.5K | 0.01% | 508 |
|
|
2023
Q3 | $822K | Buy |
105,811
+673
| +0.6% | +$5.23K | 0.01% | 510 |
|
|
2023
Q2 | $1.02M | Buy |
105,138
+11,206
| +12% | +$108K | 0.01% | 487 |
|
|
2023
Q1 | $1.03M | Sell |
93,932
-2,555
| -3% | -$28K | 0.01% | 463 |
|
|
2022
Q4 | $417K | Buy |
96,487
+18,992
| +25% | +$82K | ﹤0.01% | 662 |
|
|
2022
Q3 | $583K | Sell |
77,495
-6,590
| -8% | -$49.6K | 0.01% | 567 |
|
|
2022
Q2 | $845K | Buy |
+84,085
| New | +$845K | 0.01% | 502 |
|
|
2021
Q4 | – | Sell |
-157,076
| Closed | -$3.48M | – | 895 |
|
|
2021
Q3 | $3.48M | Sell |
157,076
-10,525
| -6% | -$233K | 0.03% | 200 |
|
|
2021
Q2 | $2.17M | Sell |
167,601
-61,176
| -27% | -$793K | 0.02% | 310 |
|
|
2021
Q1 | $2.97M | Buy |
228,777
+962
| +0.4% | +$12.5K | 0.03% | 218 |
|
|
2020
Q4 | $3.15M | Buy |
227,815
+66,456
| +41% | +$919K | 0.04% | 208 |
|
|
2020
Q3 | $2.38M | Buy |
161,359
+7,815
| +5% | +$115K | 0.04% | 210 |
|
|
2020
Q2 | $2.5M | Buy |
+153,544
| New | +$2.5M | 0.03% | 213 |
|
|
2017
Q4 | – | Sell |
-82,163
| Closed | -$515K | – | 845 |
|
|
2017
Q3 | $515K | Buy |
82,163
+8,056
| +11% | +$50.5K | ﹤0.01% | 452 |
|
|
2017
Q2 | $454K | Buy |
+74,107
| New | +$454K | ﹤0.01% | 601 |
|